Methionine (Met) is a common amino acid found in almost all proteins. When it undergoes oxidation (a common process in aging and disease), it transforms into methionine sulfoxide (Met-SO).The challenge is that this chemical reaction creates a new chiral center at the sulfur atom. This means that for every oxidized methionine, two different mirror-image versions (diastereomers) can exist: The (S,S) form and the (S,R) form.Before this invention, researchers struggled to separate these two forms. This resulted in two major technical hurdles:Standard techniques like High Performance Liquid Chromatography (HPLC) or fractional crystallization (a method dating back to 1947) were unreliable, difficult to reproduce, and failed to produce high-purity samplesBecause the two forms were so difficult to separate, almost all previous research on methionine oxidation used a mixture of both. This meant that if one form was toxic and the other was harmless, the results would be averaged out, hiding the true biological mechanism.A core motivation for this invention is the "staggering degree of disagreement" in Alzheimer's Disease research regarding the protein Amyloid beta (Aβ42)Some studies claimed that oxidized Aβ42 increased brain plaque toxicity, while others claimed it decreased itIt is plausible that these contradictions exist because previous researchers didn't know which specific diastereomer—(S,S) or (S,R)—they were testinOnce these two forms are created, they are remarkably stable. The energy barrier to flip from one form to the other is roughly 45.2 kcal/mol, which is significantly higher than other enantiomeric structures. This means that in the human body, the "wrong" version won't just flip back to the "right" one; it stays in that specific shape, potentially causing long-term damage if not properly regulated by specific enzymes (reductases). 

Comprehensive radiation detection across the spectral range requires distinct systems for ionizing and non-ionizing imaging because each technology faces unique architectural hurdles. Modern visible light detection has successfully transitioned from passive plates to digital Active Pixel Sensors (APS) by leveraging Complementary Metal-Oxide-Semiconductor (CMOS) technology to provide every pixel with its own dedicated amplifier and active circuitry. Ionizing radiation detection like X-ray and gamma-ray has relied on exotic scintillators to convert radiation into light, a process prone to lateral light scattering and degraded spatial resolution. Recent advancements in ionizing radiation have shifted toward direct conversion materials like amorphous selenium (a-Se), which transform X-rays directly into electrical charges. However, these direct-conversion devices often struggle to scale to larger areas without significant noise penalties. This is primarily due to thin-film transistor (TFT) backplanes which, unlike their CMOS counterparts, lack the local amplification necessary to maintain a high signal-to-noise ratio.

Reactive oxygen species (ROS), including hydrogen peroxide and peroxynitrite, play dual roles as essential signaling molecules and high-stress markers of cellular damage. However, imaging these volatile species in live biological systems is often hindered by diffusion and poor signal localization. Researchers at UC Berkeley have developed a "tandem" activity-based sensing and labeling strategy that overcomes these challenges. This technology utilizes selective chemical probes that, upon reacting with a specific ROS, undergo a transformation that simultaneously triggers a fluorescent signal and anchors the probe to nearby cellular proteins. By "trapping" the signal at the site of its production, this dual-action mechanism allows for high-resolution, localized imaging of oxidative stress and signaling events within complex cellular environments.

Glaucoma remains a leading cause of irreversible blindness worldwide, primarily due to the progressive degeneration of retinal ganglion cells. While traditional treatments focus on reducing intraocular pressure, they often fail to stop the underlying neurodegenerative process. UC Berkeley researchers have developed a novel neuroprotective strategy that involves modulating the activity of ocular serpinA3. By administering a serpinA3 polypeptide or a nucleic acid encoding the polypeptide directly to the eye, this technology aims to shield ocular tissues from damage and preserve visual function. This approach represents a significant shift toward directly protecting the nervous system of the eye, offering hope for patients who continue to lose vision despite controlled eye pressure.

Achieving a balance between high toughness and elasticity in polymer science is traditionally difficult, as increasing one property often compromises the other. To overcome this limitation, researchers at UC Berkeley have developed a method using crystalline woven and interlocked covalent organic frameworks (COFs) as structural additives. By incorporating these molecularly "woven" frameworks into polymer matrices, the resulting composite materials benefit from the unique mechanical energy dissipation provided by the interlocked COF threads. This molecular weaving approach allows for the creation of advanced materials that possess exceptional strength and flexibility, far surpassing the mechanical performance of standard polymers.

Reducing atmospheric carbon dioxide levels is essential for mitigating climate change, yet capturing and converting CO2 from ambient air remains a significant technical hurdle. UC Berkeley researchers have invented a modular, integrated system that directly captures CO2 from the air and converts it into high-value products. The process utilizes specialized sorbents, such as functionalized metal-organic frameworks (MOFs) or covalent organic frameworks (COFs), to isolate CO2 from the atmosphere. In a two-step bioreactor sequence, autotrophic microorganisms first convert the purified CO2 into an organic intermediate, like acetate, using electrochemically generated hydrogen as an energy source. A second population of metabolically engineered microbes then utilizes this intermediate as a feedstock to synthesize specific value-added products, ranging from fuels and biopolymers to pharmaceuticals and industrial enzymes.

Selectively modifying specific amino acids in proteins is a cornerstone of modern chemical biology and drug development, yet tryptophan remains a challenging target due to its unique chemical properties. UC Berkeley researchers have developed a redox-based strategy for the chemoselective bioconjugation of tryptophan using oxaziridine reagents. This technology mimics the oxidative cyclization reactions found in natural indole-based alkaloid biosynthetic pathways to achieve highly selective and rapid labeling. By leveraging this biomimetic approach, the method allows for the precise modification of tryptophan residues in complex biological systems, offering a robust tool for creating stable and functional protein conjugates.

Monitoring humidity and water vapor levels in industrial and consumer settings often requires electronic sensors or integrated chemical dyes that can be prone to failure or degradation. To simplify this process, UC Berkeley researchers have developed hydrochromic reticular materials that integrate color-changing functionality directly into a porous adsorbent framework. These materials consist of a metal-modified reticular structure where color transitions are intrinsically coupled to the adsorption and desorption of water molecules within the porous architecture. By providing a direct visual response based on the material's internal hydration state, this technology enables robust, real-time monitoring of water vapor without the need for external electronic components, separate indicators, or complex power sources.